Hyphens Pharma International Ltd
SGX:1J5
Hyphens Pharma International Ltd
Net Income (Common)
Hyphens Pharma International Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Net Income (Common)
S$10.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Net Income (Common)
-$97m
|
CAGR 3-Years
7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Net Income (Common)
S$228.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Net Income (Common)
-S$9.7m
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Hyphens Pharma International Ltd
Glance View
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
See Also
What is Hyphens Pharma International Ltd's Net Income (Common)?
Net Income (Common)
10.2m
SGD
Based on the financial report for Dec 31, 2024, Hyphens Pharma International Ltd's Net Income (Common) amounts to 10.2m SGD.
What is Hyphens Pharma International Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
9%
Over the last year, the Net Income (Common) growth was 19%. The average annual Net Income (Common) growth rates for Hyphens Pharma International Ltd have been 14% over the past three years , 9% over the past five years .
You don't have any saved screeners yet